The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats

Fundamental and Clinical Pharmacology

Volumn 29, Issue 3, 2015, Pages 299-309

  Motaghinejad, Majid ^a   Karimian, Seyed Morteza ^b   Motaghinejad, Ozra ^a   Shabab, Behnaz ^c   Asadighaleni, Majid ^c   Fatima, Sulail ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IranNajo Pharmaceutical Co   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cortisol; Morphine; Oxidative stress; Withdrawal syndrome

Indexed keywords

CASPASE 3; CASPASE 9; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROCORTISONE; INTERLEUKIN 1BETA; MORPHINE; NALOXONE; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; APOPTOSIS REGULATORY PROTEIN; AUTACOID; BIOLOGICAL MARKER; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HYDROCORTISONE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MORPHINE ADDICTION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; BLOOD; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; MORPHINE DEPENDENCE; PATHOLOGY; PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTOR; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; ANXIETY; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BEHAVIOR, ANIMAL; BIOMARKERS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; HYDROCORTISONE; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NERVE DEGENERATION; OXIDATIVE STRESS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 84929286368     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/fcp.12121     Document Type: Article

References (46)

1. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med. (2005) 352 1324-1334.
2. Ueda H., Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence. Front. Biosci. (Landmark Ed). (2008) 14 5260-5272.
3. Bierczynska-Krzysik A., Bonar E., Drabik A. et al. Rat brain proteome in morphine dependence. Neurochem. Int. (2006) 49 401-406.
4. Bajic D., Commons K.G., Soriano S.G. Morphine-enhanced apoptosis in selective brain regions of neonatal rats. Int. J. Dev. Neurosci. (2013) 31 258-266.
5. Tai Y.-H., Wang Y.-H., Wang J.-J., Tao P.-L., Tung C.-S., Wong C.-S. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain (2006) 124 77-86.
6. Lim G., Wang S., Lim J., Mao J. Activity of adenylyl cyclase and protein kinase A contributes to morphine-induced spinal apoptosis. Neurosci. Lett. (2005) 389 104-108.
7. Lin X., Wang Y.J., Li Q. et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J. (2009) 276 2022-2036.
8. Nasiraei-Moghadam S., Kazeminezhad B., Dargahi L., Ahmadiani A. Maternal oral consumption of morphine increases Bax/Bcl-2 ratio and caspase 3 activity during early neural system development in rat embryos. J. Mol. Neurosci. (2010) 41 156-164.
9. Rivo J., Zeira E., Galun E., Einav S., Linden J., Matot I. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock (2007) 27 266-273.
10. Sawaya B.E., Deshmane S.L., Mukerjee R., Fan S., Khalili K. TNF alpha production in morphine-treated human neural cells is NF-κB-dependent. J. Neuroimmune Pharmacol. (2009) 4 140-149.
11. Shavit Y., Wolf G., Goshen I., Livshits D., Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain (2005) 115 50-59.
12. Guzmán D.C., Vázquez I.E., Brizuela N.O. et al. Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brain. Neurochem. Res. (2006) 31 549-554.
13. Özmen I˙., Naziroğlu M., Alici H.A., Şahin F., Cengiz M., Eren I. Spinal morphine administration reduces the fatty acid contents in spinal cord and brain by increasing oxidative stress. Neurochem. Res. (2007) 32 19-25.
14. Zou S., Fitting S., Hahn Y.-K. et al. Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia. Brain (2011) 134 3613-3628.
15. Afify E.A., Khedr M.M., Omar A.G., Nasser S.A. The involvement of KATP channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats. Fundam. Clin. Pharmacol. (2013) 27 623-631.
16. Motaghinejad M., Ebrahimzadeh A., Shabab B. Preventive effect of central administration of venlafaxine on morphine physical dependence, nociception, and blood cortisol level in rat. Int. J. Prev. Med. (2014) 5 1422-1431.
17. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. (1992) 12 2439-2450.
18. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. (2001) 10 201-217.
19. Robison A.J., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. (2011) 12 623-637.
20. Nestler E.J., Barrot M., Self D.W. ΔFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. U.S.A. (2001) 98 11042-11046.
21. Muller D.L., Unterwald E.M. In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J. Pharmacol. Exp. Ther. (2004) 310 774-782.
22. Parlato R., Cruz H., Otto C. et al. Effects of the cell type-specific ablation of the cAMP-responsive transcription factor in noradrenergic neurons on locus coeruleus firing and withdrawal behavior after chronic exposure to morphine. J. Neurochem. (2010) 115 563-573.
23. Roy S., Wang J., Kelschenbach J., Koodie L., Martin J. Modulation of immune function by morphine: implications for susceptibility to infection. J. Neuroimmune Pharmacol. (2006) 1 77-89.
24. Motaghinejad M., Karimian M., Motaghinejad O., Shabab B., Yazdani I., Fatima S. Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus. Pharmacol. Rep. (2015) 67 230-235.
25. Navarro A., Bandez M.J., Lopez-Cepero J.M., Gómez C., Boveris A. High doses of vitamin E improve mitochondrial dysfunction in rat hippocampus and frontal cortex upon aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2011) 300 R827-R834.
26. Niknahada H., Taghdirib A., Mohammadi-Bardborib A., Mehrabadib A.R. Protective effect of captopril against doxorubicin-induced oxidative stress in isolated rat liver mitochondria. Iran. J. Pharm. Sci. (2010) 6 91-98.
27. Mitsopoulos P., Suntres Z.E. Protective effects of liposomal N-acetylcysteine against paraquat-induced cytotoxicity and gene expression. J. Toxicol. (2011) 2011 808967.
28. Carr W.J., Oberley-Deegan R.E., Zhang Y., Oberley C.C., Oberley L.W., Dunnwald M. Antioxidant proteins and reactive oxygen species are decreased in a murine epidermal side population with stem cell-like characteristics. Histochem. Cell Biol. (2011) 135 293-304.
29. Ehrnhoefer D.E., Skotte N.H., Savill J. et al. A quantitative method for the specific assessment of caspase-6 activity in cell culture. PLoS ONE (2011) 6 e27680.
30. Connor T.J., Harkin A., Kelly J.P. Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-α independent of a β-adrenoceptor-mediated increase in interleukin-10. J. Pharmacol. Exp. Ther. (2005) 312 134-143.
31. Chartoff E.H., Mague S.D., Barhight M.F., Smith A.M., Carlezon W.A. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J. Neurosci. (2006) 26 6450-6457.
32. Seyedi S.Y., Salehi F., Payandemehr B. et al. Dual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine-dependent mice. Fundam. Clin. Pharmacol. (2014) 28 445-454.
33. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology (2004) 47 24-32.
34. Esmaeili Mahani S., Motamedi F., Javan M., Ahmadiani A. Involvement of hypothalamic pituitary adrenal axis on the effects of nifedipine in the development of morphine tolerance in rats. Pharmacol. Biochem. Behav. (2005) 81 152-157.
35. Feng Y., Lu Y., Lin X. et al. Endomorphins and morphine limit anoxia-reoxygenation-induced brain mitochondrial dysfunction in the mouse. Life Sci. (2008) 82 752-763.
36. Hsiao P.-N., Chang M.-C., Cheng W.-F. et al. Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology (2009) 256 83-91.
37. Payabvash S., Beheshtian A., Salmasi A.H. et al. Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver. Life Sci. (2006) 79 972-980.
38. Zhou J., Li Y., Yan G. et al. Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotox. Res. (2011) 20 334-342.
39. Rozisky J., Laste G., de Macedo I. et al. Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats. Neurochem. Res. (2013) 38 494-503.
40. Adluri R.S., Nagarajan D., Periyaswamy V., Venugopal P.M. Dose-response effect of ferulic acid against nicotine-induced tissue damage and altered lipid levels in experimental rats: a pathohistological evaluation. Fundam. Clin. Pharmacol. (2008) 22 557-567.
41. Hritcu L., Ciobica A., Gorgan L. Nicotine-induced memory impairment by increasing brain oxidative stress. Cent. Eur. J. Biol. (2009) 4 335-342.
42. Rodrigo R., Guichard C., Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam. Clin. Pharmacol. (2007) 21 111-127.
43. Li Y., Sun X., Zhang Y. et al. Morphine promotes apoptosis via TLR2, and this is negatively regulated by β-arrestin 2. Biochem. Biophys. Res. Commun. (2009) 378 857-861.
44. Emeterio E.P.S., Tramullas M., Hurlé M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. J. Neurosci. Res. (2006) 83 1352-1361.
45. Shen C.-H., Tsai R.-Y., Shih M.-S. et al. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth. Analg. (2011) 112 454-459.
46. Wang J., Barke R.A., Charboneau R., Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J. Immunol. (2005) 174 426-434.